Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|December 20, 2021
[Dental care behavior and related factors during the COVID-19 state of emergency in Japan]Asuka Takeda, Hideki Fukuda, Toshihiko Kitahara, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 3, 2008
[HIV-related multiple non-Hodgkin lymphomas]Moritaka Gotoh, Toshihiko Kitahara, Tomotaka Iguchi, et al.Hematology (Amsterdam, Netherlands)|June 15, 2011
Non-random chromosomal deletion clustering at 20q in Waldenström macroglobulinemiaToshihiko Kitahara, Tomohiro Umezu, Keiko Ando, et al.International Journal of Hematology|January 5, 2010
Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR-ABL mutationMoritaka Gotoh, Tetsuzo Tauchi, Seiichiro Yoshizawa, et al.Internal Medicine (Tokyo, Japan)|February 1, 2023
Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin TherapyYo Kawarada, Ryujiro Hara, Toshihiko Kitahara, et al.Cancer Biology & Therapy|October 9, 2013
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with nilotinib against BCR-ABL-positive leukemia cells involves the ABL kinase domain mutationSeiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, et al.Plos One|March 4, 2014
Combining the ABL1 kinase inhibitor ponatinib and the histone deacetylase inhibitor vorinostat: a potential treatment for BCR-ABL-positive leukemiaSeiichi Okabe, Tetsuzo Tauchi, Shinya Kimura, et al.Case Reports in Oncology|December 24, 2021
The Effect of Roxadustat on Transfusion-Dependent Myelodysplastic Syndrome Complicated by Chronic Kidney DiseaseRyujiro Hara, Naoki Goto, Daisuke Furuya, et al.Hematology (Amsterdam, Netherlands)|December 1, 2010
Determination of donor-derived killer immunoglobulin-like receptor (KIR) by sequential genotyping in hematopoietic stem cell-transplanted patientsSeiichiro Yoshizawa, Toshihiko Kitahara, Yu Zhang, et al.International Journal of Hematology|December 27, 2022
Fetal hemoglobin level predicts lower-risk myelodysplastic syndromeRyujiro Hara, Toshihiko Kitahara, Hiroki Numata, et al.Pageof 2